Wednesday, 30 August, 2023

Quanthealth Expands AI-Informed Clinical Drug Trials to US with $15M Funding

Quanthealth has secured $15 million in funding to introduce its AI-informed clinical drug trials to the United States. The company's innovative approach uses artificial intelligence to optimize drug trial processes, promising faster and more efficient outcomes. As Quanthealth extends its operations, this funding round highlights growing interest and investment in leveraging AI for advancing medical research and enhancing the pharmaceutical industry's capabilities in the US market.